This post was originally published on this site
Furthermore, the inelastic demand for healthcare products should help the industry perform well even if economic growth slows due to the resurgence of COVID-19 cases.
We think rising investor optimism about the industry’s growth prospects should drive the performance of fundamentally sound healthcare stocks UnitedHealth Group Incorporated (NYSE:UNH), Eli Lilly and Company (LLY), and Abbott Laboratories (NYSE:ABT) in the near term.
